- Conditions
- Diphtheria, Hepatitis B, Poliomyelitis, Pertussis, Tetanus
- Interventions
- DTaP-Hep B-IPV Vaccine, Monovalent Hep B Vaccine, Placebo
- Biological · Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- Up to 5 Days
- Enrollment
- 5 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Torrance, California
Source: ClinicalTrials.gov public record
Updated Nov 6, 2011 · Synced May 21, 2026, 10:06 PM EDT